Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2009-04-02 17:25:00 UTC
Update Date2022-03-07 02:51:21 UTC
HMDB IDHMDB0012109
Secondary Accession Numbers
  • HMDB12109
Metabolite Identification
Common Name5,6-Dihydroxyprostaglandin F1a
DescriptionProstaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways.
Structure
Data?1582753013
Synonyms
ValueSource
5,6-Hydroxyprostaglandin F1alphaHMDB
ProstaglandinsHMDB
5,6-Dihydroxyprostaglandin F1MeSH, HMDB
5,6-DH-PGF1MeSH, HMDB
7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-5,6-dihydroxyheptanoateGenerator, HMDB
Chemical FormulaC20H36O7
Average Molecular Weight388.4956
Monoisotopic Molecular Weight388.246103506
IUPAC Name7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-5,6-dihydroxyheptanoic acid
Traditional Name7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-5,6-dihydroxyheptanoic acid
CAS Registry Number11000-26-3
SMILES
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(O)=O
InChI Identifier
InChI=1S/C20H36O7/c1-2-3-4-6-13(21)9-10-14-15(18(24)12-17(14)23)11-19(25)16(22)7-5-8-20(26)27/h9-10,13-19,21-25H,2-8,11-12H2,1H3,(H,26,27)/b10-9+/t13-,14+,15+,16?,17+,18-,19?/m0/s1
InChI KeySAAOVBGAFHJPIF-NYNACFBQSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassFatty Acyls
Sub ClassEicosanoids
Direct ParentProstaglandins and related compounds
Alternative Parents
Substituents
  • Prostaglandin skeleton
  • Long-chain fatty acid
  • Fatty alcohol
  • Hydroxy fatty acid
  • Cyclopentanol
  • Cyclic alcohol
  • Secondary alcohol
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Carboxylic acid derivative
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organic oxide
  • Alcohol
  • Organic oxygen compound
  • Carbonyl group
  • Aliphatic homomonocyclic compound
Molecular FrameworkAliphatic homomonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
Process
Role
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility1.4 g/LALOGPS
logP1.14ALOGPS
logP0.51ChemAxon
logS-2.4ALOGPS
pKa (Strongest Acidic)4.14ChemAxon
pKa (Strongest Basic)-1.6ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count6ChemAxon
Polar Surface Area138.45 ŲChemAxon
Rotatable Bond Count13ChemAxon
Refractivity102.39 m³·mol⁻¹ChemAxon
Polarizability44.11 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+192.68831661259
DarkChem[M-H]-194.77831661259
DeepCCS[M+H]+205.63630932474
DeepCCS[M-H]-203.2430932474
DeepCCS[M-2H]-236.33730932474
DeepCCS[M+Na]+211.54930932474
AllCCS[M+H]+202.332859911
AllCCS[M+H-H2O]+199.932859911
AllCCS[M+NH4]+204.532859911
AllCCS[M+Na]+205.232859911
AllCCS[M-H]-197.532859911
AllCCS[M+Na-2H]-198.732859911
AllCCS[M+HCOO]-200.132859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. 4.17 minutes32390414
Predicted by Siyang on May 30, 202210.6081 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20224.2 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid195.6 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid2019.3 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid181.5 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid123.2 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid174.8 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid133.0 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid376.3 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid390.6 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)333.7 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid772.9 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid386.5 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1196.0 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid242.8 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid288.1 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate514.0 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA237.7 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water169.4 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
5,6-Dihydroxyprostaglandin F1aCCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(O)=O4970.4Standard polar33892256
5,6-Dihydroxyprostaglandin F1aCCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(O)=O2942.1Standard non polar33892256
5,6-Dihydroxyprostaglandin F1aCCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(O)=O3204.6Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
5,6-Dihydroxyprostaglandin F1a,1TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O)O[Si](C)(C)C3272.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,1TMS,isomer #2CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O3175.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,1TMS,isomer #3CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O3155.2Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,1TMS,isomer #4CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O3211.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,1TMS,isomer #5CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C3257.0Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,1TMS,isomer #6CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C3212.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O)O[Si](C)(C)C3136.1Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #10CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O3116.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #11CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C3122.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #12CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C3121.0Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #13CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C3208.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #14CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C3164.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #15CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3187.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O)O[Si](C)(C)C3141.0Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #3CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O)O[Si](C)(C)C3200.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #4CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C3243.0Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #5CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3210.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #6CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O3111.2Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #7CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O3129.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #8CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C3141.1Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TMS,isomer #9CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C3138.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O)O[Si](C)(C)C3031.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #10CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C3140.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #11CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O3059.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #12CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C3047.9Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #13CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C3036.9Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #14CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C3107.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #15CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C3058.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #16CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3059.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #17CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C3097.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #18CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C3048.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #19CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3045.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O)O[Si](C)(C)C3087.2Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #20CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3134.2Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #3CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C3086.2Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #4CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3044.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #5CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O)O[Si](C)(C)C3091.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #6CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C3081.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #7CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3053.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #8CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C3179.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TMS,isomer #9CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3119.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O)O[Si](C)(C)C3021.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #10CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C3083.1Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #11CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C3046.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #12CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C2996.1Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #13CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2987.2Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #14CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3041.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #15CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3031.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C3010.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #3CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2981.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #4CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C3069.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #5CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3002.1Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #6CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C3016.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #7CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C3069.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #8CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C3009.2Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TMS,isomer #9CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C3014.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,5TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C3027.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,5TMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2984.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,5TMS,isomer #3CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C2981.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,5TMS,isomer #4CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C3001.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,5TMS,isomer #5CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C3008.1Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,5TMS,isomer #6CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2993.9Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,6TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CC(O[Si](C)(C)C)C(CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C2987.9Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,1TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O)O[Si](C)(C)C(C)(C)C3508.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,1TBDMS,isomer #2CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O3394.2Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,1TBDMS,isomer #3CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O3375.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,1TBDMS,isomer #4CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O3470.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,1TBDMS,isomer #5CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C3513.1Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,1TBDMS,isomer #6CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C3476.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O)O[Si](C)(C)C(C)(C)C3598.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #10CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O3558.1Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #11CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C3573.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #12CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C3574.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #13CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C3701.1Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #14CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C3665.2Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #15CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3701.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O)O[Si](C)(C)C(C)(C)C3589.0Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #3CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O)O[Si](C)(C)C(C)(C)C3695.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #4CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3746.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #5CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3709.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #6CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O3522.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #7CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O3571.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #8CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C3588.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,2TBDMS,isomer #9CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C3587.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O)O[Si](C)(C)C(C)(C)C3722.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #10CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3928.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #11CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O3701.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #12CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C3712.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #13CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C3727.1Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #14CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C3781.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #15CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C3770.6Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #16CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3788.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #17CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C3769.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #18CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C3754.9Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #19CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3768.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O)O[Si](C)(C)C(C)(C)C3777.0Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #20CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3880.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #3CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3799.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #4CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3811.2Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #5CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O)O[Si](C)(C)C(C)(C)C3769.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #6CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3790.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #7CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3811.0Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #8CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3917.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,3TBDMS,isomer #9CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3898.3Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O)O[Si](C)(C)C(C)(C)C3922.9Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #10CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C4098.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #11CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C3934.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #12CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C3909.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #13CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3918.0Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #14CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3983.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #15CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3966.0Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3931.9Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #3CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3936.4Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #4CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3994.8Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #5CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3968.7Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #6CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3998.5Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #7CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(CCCC(=O)O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3994.2Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #8CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)C(O)CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3971.0Semi standard non polar33892256
5,6-Dihydroxyprostaglandin F1a,4TBDMS,isomer #9CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CC(O)C(CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3996.1Semi standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 5,6-Dihydroxyprostaglandin F1a GC-MS (Non-derivatized) - 70eV, Positivesplash10-00xr-1349000000-f0b59b0ead1bee71bd0f2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 5,6-Dihydroxyprostaglandin F1a GC-MS (4 TMS) - 70eV, Positivesplash10-03di-2011329000-b3b1bd1f09bf03a400632017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 5,6-Dihydroxyprostaglandin F1a GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 10V, Positive-QTOFsplash10-0uk9-0019000000-0c248abdc713863b42252017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 20V, Positive-QTOFsplash10-0umi-5169000000-f3b47d0d3fd3d97b6b562017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 40V, Positive-QTOFsplash10-00fu-9253000000-001b20b11ee46a194d222017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 10V, Negative-QTOFsplash10-00kr-0009000000-21ff6309d44e258d39fc2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 20V, Negative-QTOFsplash10-014i-2269000000-b613e3009123a6987f8f2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 40V, Negative-QTOFsplash10-0a4i-9650000000-582a1d2f5c8d7a77c3fa2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 10V, Negative-QTOFsplash10-000i-0009000000-9ee774201b36b1e6afa82021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 20V, Negative-QTOFsplash10-0udj-4269000000-755cc230f46d576ae0982021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 40V, Negative-QTOFsplash10-0f6w-9650000000-bb65b2f9532d67019b012021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 10V, Positive-QTOFsplash10-0udi-0019000000-217bd42b5df143496b322021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 20V, Positive-QTOFsplash10-0uk9-7279000000-afa1ce55a29129f878692021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 5,6-Dihydroxyprostaglandin F1a 40V, Positive-QTOFsplash10-052f-9200000000-e56b6b22f7ad8834bc182021-09-25Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
  • Membrane
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB028773
KNApSAcK IDNot Available
Chemspider ID4944203
KEGG Compound ID C06475
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound6439819
PDB IDNot Available
ChEBI ID139312
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
  2. Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
  3. Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
  4. Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
  5. Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.